In this model, treatment with OPN-neutralising antibodies abrogated B-ALL/BM-MSC adhesion and increased tumour cell Ki67 expression and BM tumour burden, supporting the conclusion that OPN contributes to the quiescence of B-ALL blasts within the BM. This evidence concerns the gene SPP1 and precursor B-cell acute lymphoblastic leukemia.